Active substance
Piracetam
- SFDA 7
- NHS prices 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| NOOTROPIL 12GM-60ML INFUSION SOLU | 20 mg/ml | Solution for injection · Intravenous use | 1 Vial | SAR 25.85 | NCE · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
| NOOTROPIL 800 MG FILM COATED | 800 mg | Film-coated tablet · Oral use | 30 Blister | SAR 27.95 | NCE · Prescription | Glaxo Saudi Arabia Ltd. | Withdrawn by MAH · Not Marketed |
| NOOTROPIL AMP 1GM-5ML | 200 mg/ml | Solution for injection · Intravenous use | 12 Ampoule | SAR 29.25 | NCE · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
| NOOTROPIL AMP 1GM-5ML | 200 mg/ml | Solution for injection · Intravenous use | 4 Ampoule | SAR 23.10 | NCE · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
| NOOTROPIL CAPS 400MG | 400 mg | Capsule · Oral use | 60 Blister | SAR 28.90 | NCE · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
| NOOTROPIL SOLN 20% | 200 mg/ml | Oral solution · Oral use | 1 Bottle | SAR 32.65 | NCE · Prescription | GLAXOSMITHKLINE (GSK) | Withdrawn by MAH · Not Marketed |
| PIRACETAM CAPS 400MG | 400 mg | Capsule, hard · Oral use | 20 Blister | SAR 8.95 | Generic · Prescription | ALMIRALL PRODES PHARMA S.A. | Withdrawn by MAH · Not Marketed |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Piracetam 1.2g tablets | £10.97 | 60 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Piracetam 800mg tablets | £11.75 | 90 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.